🇺🇸 FDA

Intelligence · Patent portfolio

Sana Biotechnology Patents

Full USPTO pharma patent portfolio for Sana Biotechnology — grant dates, expiration, and drug cross-links.

Patents
136
Expiring ≤24m
2

Quick answer

Sana Biotechnology has 136 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 3

  1. US 10471051

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10441646

    Infectious plasmodium sporozoites grown in vitro

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10316039

    P2X3 and/or P2X2/3 compounds and methods

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10316080

    Protein-polymer-drug conjugates

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10272146

    Purified plasmodium and vaccine compositions

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10226535

    Auristatin compounds and conjugates thereof

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10226468

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10188654

    Uses of pyrimido-pyridazinones to treat cancer

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10183944

    Pyrimido-pyridazinone compounds and methods of use thereof

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10174039

    P2X3 and/or P2X2/3 compounds and methods

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10143695

    Pyrrolobenzodiazepines and conjugates thereof

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10130618

    Pharmaceutical combinations of dabigatran and proton pump inhibitors

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10111957

    Inhalation compositions comprising glucose anhydrous

    Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10105316

    Inhalation compositions comprising muscarinic receptor antagonist

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9980931

    Use of glycyl glutamine against depression

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9943609

    Protein-polymer-drug conjugates

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9944637

    P2X3 and/or P2X2/3 compounds and methods

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9931389

    Genetic attenuation of plasmodium by B9 gene disruption

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9908879

    P2X3 and/or P2X2/3 compounds and methods

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9896445

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9878026

    Infectious plasmodium sporozoites grown in vitro

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9872918

    Hydroxyl-polymer-drug-protein conjugates

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9849191

    Protein-polymer-drug conjugates

    Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9808528

    Protein-polymer-drug conjugates and methods of using same

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9795592

    Pharmaceutical formulations of vildagliptin

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9770519

    Protein-polymer-drug conjugates

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9757382

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9738720

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9642909

    Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants

    Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9616115

    Purified plasmodium and vaccine compositions

    Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9586925

    1-(dimethylamino)ethyl-substituted 6H-benzo[C]chromen-6-ones against senile dementia

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9555112

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9533981

    Pyridine derivatives

    Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9499495

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9433601

    Chewing gum compositions comprising cannabinoids

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9415023

    Compositions comprising terpene compounds for treating negative sensory phenomena

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9382277

    Pyrimido-pyridazinone compounds and methods of use thereof

    Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9375423

    Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

    Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9371316

    Pyridine derivatives

    Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9283220

    Compositions of opioid antagonists and methods for treating conditions caused by the varicella-zoster virus therewith

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9278125

    Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9266873

    Pyridine derivatives

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9254339

    Protein-polymer-drug conjugates

    Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9241982

    Purified plasmodium and vaccine compositions

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9205032

    Pressed tablet tissue application box

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9199975

    Biaryl imidazole derivatives for regulating CYP17

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9180115

    Cyclohexylamines

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9144615

    Protein-polymer-drug conjugates

    Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Sana Biotechnology have?

136 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Sana Biotechnology patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.